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Reconstructive surgery for complex aortoiliac
occlusive disease in young adults
Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca Tolin, MD,
Giuseppe Da Giau, MD, and Antonio Toniato, MD, Padova, Italy
Background: Although aortoiliofemoral bypass grafting is the optimal revascularization method for patients with severe
aortoiliac occlusive disease (AIOD), previous studies have documented poor patency rates in young adults. This study
investigated whether young patients with AIOD have worse outcomes in patency, limb salvage, and long-term survival
rates after reconstructive surgery than their older counterparts.
Methods: Patients aged<50 years undergoing reconstructive surgery at our institution for AIOD between 1995 and 2010
were compared with a cohort of randomly selected patients aged>60 years (two for each of the young patients, matched
for year of operation), analyzing demographics, risk factors, indications for surgery, operative details, and outcomes.
Results: Among 927 consecutive patients undergoing primary surgery for AIOD, 78 (8.4%) aged <50 years (mean age,
48.4 years) and 156 older control patients (mean age, 71.2 years) were identified. The younger patients were mainly men
(81%) and 59% had surgery for limb salvage and 41% for disabling claudication (P .02). Compared with older patients,
they were significantly more likely to be smokers (90% vs 72%; P  .002) and had previously needed significantly more
inflow procedures (28% vs 16%; P  .03). Only one death occurred perioperatively (30-day) among the control patients,
and no major amputations or graft infections occurred in either group. The need for subsequent infrainguinal
reconstructions was greater in the younger patients (18% vs 7%; P  .01). The primary patency rates were inferior in the
younger patients at 5 years (82% and 75%) and 10 years (95% and 90%; P .01), whereas assisted secondary patency (89%
and 82% vs 96% and 91%; P  .08), secondary patency (93% and 86% vs 98% and 92%; P  .19), limb salvage (88% and
83% vs 95% and 91%; P  .13), and survival rates (87% and 76% vs 91% and 84%; P  .32) were comparable in the two
groups.
Conclusions: This study shows that despite a higher primary graft failure rate than that in older patients, aortoiliofemoral
revascularization for complex AIOD is a safe procedure for younger patients with disabling claudication or limb-
threatening ischemia, providing they are willing to follow a regular protocol to complete their postoperative surveillance
and to undergo graft revision as necessary. ( J Vasc Surg 2012;56:1606-14.)
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lAtherosclerosis is the most common cause of peripheral
vascular disease in young adults,1-4 and the aortoiliac dis-
trict the most often involved site.3,5-7 Although premature
peripheral atherosclerotic disease (PAD) has been associ-
ated with an aggressive clinical course, a poor prognosis,
and a higher arterial revascularization failure rate, few in-
vestigators have focused on young adults undergoing vas-
cular reconstructive surgery to treat aortoiliac occlusive
disease (AIOD), and they have reported contrasting results.
Several studies identified relatively unfavorable outcomes of
aortoiliac reconstructions in patients with premature ath-
erosclerosis, with 5-year patency rates as low as 50%.7,8
However, various authors reported acceptable patency
rates in patients with premature PAD primarily involving
the aortoiliac location,3,5,9-15 and others found arterial
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1606econstruction failure and major amputation rates for
oung patients with AIOD no different from those of
oung patients with infrainguinal arterial disease or disease
ffecting both districts.2,15,16
Different conclusions were also reported when other
linical conditions associated with poor outcomes in pre-
ature PAD were analyzed. Several retrospective studies
dentified factors such as diabetes mellitus (DM), cigarette
moking, arterial hypertension, the site of the PAD, small
ortic diameter, and hypercoagulable states, alone or in
arious combinations, as predictors of a rapid progres-
ion of premature PAD and poor outcomes after sur-
ery.2,5,7,16-18 Other studies contradicted these findings,
owever.10,19,20 In light of such clinical experiences, it has
een hard to draw any final conclusions and predict the
roportion of younger patients whose disease can be ex-
ected to progress or their revascularization to fail.
Although traditional surgical treatment remains the
old standard for managing extensive, complex AIOD,
ssessed as TransAtlantic Inter-Society Consensus (TASC
I) type C and D lesions,21 the recent development of
evices for crossing chronic total occlusions and experience
ained by interventionalists have increased the use of endo-
ascular procedures even for complex AIOD.22-26 Such
reatments have revealed a limited durability, however, with
ong-term primary patency rates that are still unable to
ompete with those reported for open reconstructive sur-
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Volume 56, Number 6 Ballotta et al 1607gery (74% vs 93% at 3 years), especially in younger pa-
tients.25,26 The aim of this study was to address the ques-
tion of whether younger patients with complex AIOD have
worse outcomes after reconstructive surgery in patency,
limb salvage, and long-term survival rates than their older
counterparts.
METHODS
Details of all consecutive patients who had elective
primary infrarenal abdominal aortic reconstruction to treat
AIOD at our institution between 1995 and 2010 were
prospectively stored in a vascular registry. For the purposes
of this study, the registry was queried to identify patients
aged 50 years old (group I). The control group (group
II) comprised randomly selected patients aged 60 years
old (two for each of the younger patients), matched for year
of operation. A restricted randomization, by referring to a
table of random numbers, was used to select the control
patients from among the patients aged60 years undergo-
ing reconstructive surgery for AIOD during the study
period.
The study excluded patients with systemic conditions
such as Takayasu, Buerger, fibromuscular, or aneurysmal
diseases, acute ischemia, or a history of irradiation. Patient
details included demographics; atherosclerotic risk factors,
including diabetes mellitus (DM) and smoking habits (cur-
rent smokers or smokers who had stopped 5 years previ-
ously), arterial hypertension (blood pressure140/90mm
Hg, recorded on the strength of a clinical diagnosis, includ-
ing the ongoing use of antihypertensive therapy), cardiac
disease (prior myocardial infarction, stable or unstable an-
gina, ST segment alteration on electrocardiogram), pulmo-
nary disease, cerebrovascular disease or chronic kidney dis-
ease (creatinine value 2.0 mg/dL); indication for
revascularization (disabling claudication or critical limb
ischemia); operative details; major and minor perioperative
(30-day) complications; and patency, limb salvage, and
survival rates.
All patients underwent preoperative standard digital
subtraction angiography, magnetic resonance angiogra-
phy, or computed tomography angiography, or a combina-
tion of these methods for surgical planning and to confirm
the clinical and vascular laboratory diagnosis of AIOD, as
assessed by arterial mapping with duplex ultrasound imag-
ing andmeasurement of the ankle-brachial index (ABI). All
preoperative imaging studies were also reviewed retrospec-
tively to categorize iliac artery lesions according to the
TASC II morphologic classification.21
A standardized surgical technique was used. All proce-
dures were performed by the same surgeon using a trans-
peritoneal approach through a midline incision. Separate
groin incisions were made before the prosthetic limbs were
tunneled to perform the prosthetic-to-femoral anastomo-
ses. Prosthetic material consisted of collagen-coated Da-
cron grafts in most cases and knitted polyester in the
remainder. The aortic graft size was chosen to optimize the
sizematch with the native vessels and used as a surrogate for
definite aortic diameter, which was not measured. wThe type of proximal anastomosis (end-to-end or
nd-to-side) was based on the quality of the aorta, as
stimated on preoperative imaging findings and con-
rmed intraoperatively. The proximal anastomosis was
sually performed in an end-to-side fashion, leaving a
hort graft body in an effort to enhance graft hemody-
amics, and reserving end-to-end anastomosis for pa-
ients with total occlusion of the aorta, mural aortic
hrombus, occlusion of the inferior mesenteric artery, or
evere calcifications that may make longitudinal aortic
lamping troublesome. An endarterectomy of the anas-
omotic site can be performed before starting the anas-
omosis in case of severe calcifications.
The distal anastomosis was constructed to the
ommon/external iliac or common femoral artery when
ngiographic and intraoperative findings indicated that the
istal arterial axis was widely patent. Lack of patency was
sually due to atherosclerotic involvement of the distal
ommon femoral artery, or the initial tract of the deep
emoral artery, with or without concomitant occlusion/
tenosis of the superficial femoral artery. In these cases, the
nastomosis was carried onto the deep femoral artery, after
he latter had been endarterectomized and closed with vein
atching. Proximal and distal anastomoses were always
erformed with running monofilament polypropylene su-
ures.
Our antimicrobial policy included administering intra-
enous cefazolin intraoperatively and until postoperative
ay 3 or 4. Amoxicillin-clavulanate was administered to
atients with renal failure. Intravenous amoxicillin-
lavulanate or levofloxacin was associated with cefazolin if
atients had a temperature 38°C. All patients were dis-
harged with the recommendation that they continue oral
ntimicrobial therapy with amoxicillin-clavulanate or cipro-
oxacin until the surgical wounds had healed completely.
Postoperative surveillance. After discharge, all pa-
ients took antiplatelet agents or anticoagulants only if
hey were taking anticoagulants for other reasons preop-
ratively. Postoperative surveillance included clinical ex-
minations, supplemented with duplex scans and ABI
easurements at discharge, at 30 to 60 days, at 6 months
nd 1 year, and yearly thereafter. Graft patency was
onfirmed by the presence of a palpable femoral pulse
nd by duplex scanning. Recurring symptoms or a
arked change in vascular laboratory test results
rompted further imaging investigations (digital sub-
raction angiography or computed tomography angiog-
aphy) and reintervention as necessary. Graft failure was
efined as an occlusion of the graft as a whole or of a
ingle limb graft. Primary patency, assisted primary pa-
ency, secondary patency, and limb salvage rates were
efined in accordance with the reporting standards sug-
ested by the Society for Vascular Surgery Ad Hoc
ommittee and the North American Chapter of the
nternational Society for Cardiovascular Surgery.27
Statistical analysis. Continuous data were compared
ith the Student t-test. Frequencies and categoric data
ere compared with a 2 or Fisher exact test, as appropri-
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ary patency, limb salvage, and long-term survival rates were
assessed using Kaplan-Meier analysis, and curves were com-
pared using the Mantel-Cox log-rank test. A Cox propor-
tional hazard model was used to identify the factors with
statistical or marginal significance at univariate analysis
that could influence outcomes, calculating the odds ratio
(OR) with 95% confidence intervals (95% CIs). All tests
were two-tailed, and statistical significance was inferred
at P  .05.
RESULTS
Between 1995 and 2010, 927 consecutive patients
underwent elective infrarenal abdominal aortic reconstruc-
tion for AIOD at our institution. Among them, 78 (8.4%)
who were aged50 years old (mean age, 48.4 years; range,
44-50 years) were matched with 156 control patients
(mean age, 71.2 years; range, 62-77). The younger patients
were mostly men (81%), significantly more were current or
former smokers (89.7% vs 71.8%; P  .002), and were less
likely to have cerebrovascular disease (7.7% vs 18.6%; P 
.03) then older patients (Table I). Overall, 62% (145 of
234) of the surgical reconstructions were performed for
limb salvage and 38% for disabling claudication, with sig-
nificantly more patients operated on for limb salvage than
for claudication (59% vs 41% in group I [P .02]; 63.5% vs
36.5% in group II [P  .001]). Of the 234 patients, 47
Table I. Characteristics of study population
Variablea
Gr
n
Age, years 48.4 
Male sex 63
Risk factors
Diabetes mellitus 27
Hyperlipemia 38
Hypertension 43
Smoking history 70
Chronic kidney disease 5
Cardiac disease 28
Cerebrovascular disease 6
Pulmonary disease 8
Indications for surgery
Disabling claudication 32
Critical limb ischemia 46
TASC II classification
Type B 7
Type C 29
Type D 42
Prior endovascular inflow procedures 22
PTA alone 15
PTA and stenting 7
Pre-op ABI measurement at rest
In claudication 0.52 
In critical limb ischemia 0.47 
ABI, Ankle-brachial index; PTA, percutaneous transluminal angioplasty; TA
aContinuous data are shown as the mean  standard deviation (range) and
bP  .02.
cP  .001.(20%) had undergone inflow endovascular treatments, con- tisting exclusively of percutaneous angioplasty with or
ithout stenting, 2 to 3 years before the aortoiliac recon-
truction, with significantly more such procedures in group
than in group II (28.2% vs 16%; P  .03). No significant
ifferences emerged between the two groups for any of the
ther variables considered, including sex, risk factors, co-
orbidities, TASC II classification, and ABI measurement
Table I).
Table II summarizes some technical and operative
etails for the two groups. The graft consisted of colla-
en-coated Dacron grafts (79.5% in group I vs 83.3% in
roup II) or knitted double velour (20.5% in group I vs
6.7% in group II). The proximal anastomosis was con-
tructed end-to-side in 149 of 234 patients (63.6%), with
statistically higher incidence in group I (73.1% vs
9.0%; P  .03). The younger patients required signifi-
antly fewer endarterectomies at the proximal anasto-
otic site than the older patients (6.4% vs 17.3%; P 
02) and fewer distal anastomoses constructed to an
ndarterectomized common femoral artery (8.9% vs
9.8%; P  .03) or after a concomitant profundoplasty
19.2% vs 32%; P  .03). However, the younger patients
eeded more subsequent outflow surgical procedures
18% vs 7%; P  .02), within a mean interval of 27
onths, for infrainguinal occlusive disease that most of
hem had already at the time of the aortic revasculariza-
Group I
n  156 P
4-50) 71.2  4.9 (62-77)
) 109 (69.9) .07
) 68 (43.6) .19
) 95 (60.9) .08
) 93 (59.6) .51
) 112 (71.8) .002
18 (11.5) .25
) 72 (46.1) .13
29 (18.6) .03
) 31 (19.8) .06
)b 57 (36.5)c .50
)b 99 (63.5)c .50
14 (8.9) .99
) 54 (34.6) .70
) 88 (56.4) .71
) 25 (16.0) .03
) 19 (12.2) .15
6 (3.8) .10
0.54  2.9 .96
0.46  5.8 .98
ransAtlantic Inter-Society Consensus.
ric data as number (%).oup I
 78
1.9 (4
(80.7
(34.6
(48.7
(55.1
(89.7
(6.4)
(35.9
(7.7)
(10.2
(41.0
(59.0
(8.9)
(37.2
(53.8
(28.2
(19.2
(9.0)
3.7
4.3
SC, T
categoion. No significant differences emerged between the
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Volume 56, Number 6 Ballotta et al 1609two groups in graft size, type of bypass grafting, or
number of inferior mesenteric artery reimplantations.
Perioperative mortality and morbidity data. A de-
tailed list of the perioperative outcomes is given in Table
III. Overall, the only perioperative death was one patient in
group II who died of multisystem organ failure. No graft
infections or major amputations occurred in either group.
The overall systemic and minor complication rates, includ-
ing wound infection, total or partial wound dehiscence,
inguinal lymphocele, or hematoma, were comparable be-
tween the two groups. No differences emerged between
the groups in improvement in their postoperative ABI
measurements.
Long-term outcomes. Five of the 233 patients alive
30 days after surgery (2.1%; one in group I) were lost to
follow-up, so 228 patients (77 in group I) completed the
follow-up. The mean follow-up was 88.7  2.2 months
(median, 76 months) for group I and 86.4 7.2 months
(median, 74 months) for group II. Kaplan-Meier life-
table analyses for groups I and II are presented for
primary patency (Fig 1), assisted primary patency (Fig 2),
secondary patency (Fig 3), and limb salvage rates (Fig 4).
At 5 and 10 years, the younger patients had signifi-
cantly lower primary patency rates (82% and 75%) than the
older patients (95% and 90%; OR, 2.52; 95% CI, 1.22-
6.38; log-rank test, P  .01; Fig 1).
Overall, seven patients (3%; five in group I) required
surgical revision for graft failure due to a severe symp-
tomatic stenosis of the distal anastomosis (bilaterally in
Table II. Technical and operative data
Variablea
Group I Group II
P(n  78) (n  156)
Prosthetic graft
Collagen-coated Dacron 62 (79.5) 130 (83.3) .47
Knitted double velour 16 (20.5) 26 (16.7) .47
Proximal anastomosis
End-to-end 21 (26.9) 64 (41.0) .03
End-to-side 57 (73.1) 92 (59.0) .03
Graft size, mm
18  9.5 4 (5.1) 16 (10.3) .22
16  8 66 (84.6) 119 (76.2) .14
14  7 8 (10.2) 21 (13.5) .48
Bypass grafting
Aortobiiliac 10 (12.8) 13 (8.3) .27
Aortobifemoral 59 (75.6) 124 (79.5) .50
Aortoiliac-femoral 9 (11.5) 19 (12.2) .88
Endarterectomy at the
proximal anastomotic
site 5 (6.4) 27 (17.3) .02
IMA reimplantation 4 (5.1) 5 (3.2) .47
Concomitant CFA
endarterectomy 7 (8.9) 31 (19.8) .03
Concomitant
profundoplasty 15 (19.2) 50 (32.0) .03
Subsequent outflow
procedures 14 (18.0) 11 (7.0) .01
CFA, Common femoral artery; IMA, inferior mesenteric artery.
aCategoric data are shown as number (%).four patients), treated with endarterectomy of the inti- aal hyperplasia and vein patching in all patients. The
ssisted primary patency rates at 5 and 10 years were 89%
nd 82% for group I and 96% and 91% for group II, with
o statistically significant difference between the two
roups (OR, 2.18; 95% CI, 0.87-6.11; log-rank test, P
08; Fig 2).
Two total graft occlusions (0.8%; one in group I) were
anaged surgically, one with thrombectomy and concom-
tant profundoplasty, and the other with an axillobifemoral
ypass, after repeat thrombectomy failed. In five patients
ith single limb thrombosis (2.2%; three in group I),
atency was restored by means of thrombectomy and pro-
undoplasty in one or by prosthetic crossover bypass graft-
ng in four, after thrombectomy failed to restore blood
ow. Two other total graft occlusions (0.8%; one in group
) and three single limb thromboses (1.3%; all in group I)
ere managed conservatively. The secondary patency rates
t 5 and 10 years were 93% and 86% for group I and 98%
nd 92% for group II, with no statistically significant differ-
nce between the two groups (OR, 1.94; 95% CI, 0.69-
.21; log-rank test, P  .19; Fig 3).
The younger group was more likely than the older
roup (18% vs 7%; P  .01) to require subsequent infrain-
uinal reconstructions, due more to disease progression
han to graft failure.
Overall, repeatedly failing distal arterial revasculariza-
ions resulted in 11 late major amputations (4.7%; 5 in
roup I), eight above knee and three below knee, all
nvolving patients operated for limb salvage with a patent
ortobifemoral reconstruction. The limb salvage rates at 5
able III. Perioperative (30-day) outcomes
ariablea
Group I Group II
P(n  78) (n  156)
eath 0 1 (0.6) .99
ajor complications
Cardiacb 2 (2.5) 7 (4.5) .72
Gastrointestinalc 0 3 (1.9) .55
Pulmonary failured 1 (1.3) 3 (1.9) .99
Stroke 0 1 (0.6) .99
Acute renal failure 0 0
Thrombosis of 1 limb
graft 0 1 (0.6) .66
Entire graft occlusion 0 1 (0.6) .99
Amputation 0 0
inor complicationse 5 (6.4) 11 (7.0) .99
BI measurements
In claudication 0.85  0.3 0.83  0.5 .74
In critical limb
ischemia 0.81  0.2 0.80  0.4 .83
BI, Ankle-brachial index.
Categoric data are shown as number (%) and continuous data as mean 
tandard deviation.
Arrhythmia, myocardial infarction, and congestive heart failure.
Prolonged ileus, colon ischemia, gastrointestinal bleeding, and hepatic
ailure.
Respiratory assistance for 48-72 hours.
Total or partial wound dehiscence at the groin; lymphocele or hematoma at
he groin; femoral hemorrhage.nd 10 years were 88% and 83% for group I, and 93% and
8
w
t
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between the two groups (OR, 2.38; 95% CI, 0.72-11.01;
log-rank test, P  .13; Fig 4).
Overall, there were 27 late deaths (11.8%; 11 in group
I). The main known cause of death in either group was
Fig 1. Kaplan-Meier life-table analysis is shown for the
II) patients (odds ratio [OR], 2.52; 95% confidence inte
the patients at risk and the standard error (SE) analyzed
Fig 2. Kaplan-Meier life-table analysis is shown for the a
(group II) patients (odds ratio [OR], 2.18; 95% confid
number of the patients at risk and the standard error (SEcardiac disease. The survival rates at 5 and 10 years were p7% and 76% for group I and 91% and 84% for group II,
ith no statistically significant difference between the
wo groups (OR, 1.47; 95% CI, 0.67-3.38; log-rank test,
 .32).
Univariate analysis showed smoking was the only
ry patency rates for younger (group I) and older (group
I], 1.22-6.38; log-rank test, P  .01). Raw number of
ch interval are shown for each group.
d primary patency rates for younger (group I) and older
interval [CI], 0.87-6.11; log-rank test, P  .08). Raw
lyzed for each interval are shown for each group.prima
rval [Cssiste
enceredictor of graft failure in the younger group (P 
p
f
s
d
each i
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Volume 56, Number 6 Ballotta et al 1611.001), with no significant influence on limb salvage or
long-term survival; a need for subsequent distal proce-
dure due to outflow disease was the only predictor of
limb loss (P  .001). None of other prognostic variables
Fig 3. Kaplan-Meier life-table analysis is shown for seco
patients (odds ratio [OR], 1.94; 95% confidence interval
patients at risk and the standard error (SE) analyzed for
Fig 4. Kaplan-Meier life-table analysis is shown for lim
patients with critical limb ischemia (odds ratio [OR], 2.
P .13). Raw number of the patients at risk and the stan
group.considered (demographics, risk factors, clinical data, or arior inflow endovascular procedure) could predict graft
ailure or limb loss. Multivariate analysis confirmed
moking and subsequent outflow procedures as indepen-
ent predictors, respectively, of graft failure (P  .001)
patency rates for younger (group I) and older (group II)
0.69-6.21; log-rank test, P .19). Raw number of the
nterval are shown for each group.
lvage rates for younger (group I) and older (group II)
5% confidence interval [CI], 0.72-11.01; log-rank test,
error (SE) analyzed for each interval are shown for eachndary
[CI],b sa
38; 9
dardnd limb loss (P  .001).
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The endovascular treatment of iliac occlusive disease
has evolved over the last two decades. Endovascular proce-
dures with selective stenting have had an important effect
on the management of AIOD, proving effective in treating
isolated focal iliac stenosis or occlusions and largely sup-
planting open revascularization of such lesions. The endo-
vascular treatment of multisegmental and complex AIOD
has not been so encouraging, however, especially when
diffuse lesions involve the external iliac artery.22-26,28 An
aortobifemoral bypass remains the standard treatment for
diffuse and complex AIOD,21 and is associated with a
modest perioperative mortality of 3% to 5%14,29 and excel-
lent long-term patency rates of 87% to 91% at 5 years and
82% to 87% at 10 years,29 although the cumulative late
survival remains unsatisfactory.30,31 Reports on the long-
term outcome of open reconstructive surgery in younger
people are inconsistent.
The results of the present study indicate that surgical
reconstruction to treat complex AIOD in patients aged
50 years old is a safe and durable procedure, with few
major perioperative complications, no life-threatening
risks, and good long-term patency and limb salvage rates,
despite a significantly higher primary graft failure rate than
in older patients (P  .01).
Several authors have reported worse long-term
patency rates after direct revascularization in younger
adults,7,8,14,18 whereas other surgeons have reported more
rewarding experiences in such patients.9,13,17 Our crude
primary patency rates were (1) similar to those seen in many
series in which patients were not stratified by age29; (2)
consistent with a 4-year patency rate of 93% in young
women and 89% in youngmen andwomen reported by other
investigators in the 1980s and 1990s, respectively9,11; and (3)
comparable with the 5- and 10-year patency rates of 82% and
75% observed in a more recently-published Italian study, in
which, however, the long-term outcomes were similar in
younger and older patients.13
Our data suggest that most primary treatment failures
occur 24 months after surgery and are associated not so
much with any progression of PAD as with intimal hyper-
plasia at the distal anastomotic site. Why patients with
premature PAD are more prone to intimal hyperplasia and
consequent graft failure than older patients is not still clear.
In our analysis, younger patients were more often former or
current smokers (and smoking emerged as the only inde-
pendent factor for late graft failure) and tended more to
have a history of endovascular inflow procedures. All major
investigations of premature PAD have emphasized the im-
portance of smoking as a risk factor,13-15,17-19 although the
exact mechanism behind the effect of smoking on these
younger patients, and why some individuals seem more
exposed to its harmful effects than others, are issues that
remain to be fully understood.32 Similarly, numerous stud-
ies on the influence of smoking on graft patency after PAD
reconstructive surgery21 have confirmed its association
with a higher graft failure rate.18,33 The finding of a signif- rcantly higher number of patients who had previously had
nflow procedures in our younger group is also not new;
ather than a predictor of future graft failure, this condition
ould be considered as a marker of a more aggressive form
f atherosclerosis potentially responsible for poor patency
ates or it simply could be a feature of multisegmental
isease.3,14
No differences emerged between our two age groups in
econdary patency and limb salvage rates. Adopting an
ntensive postoperative graft surveillance protocol led to
any successful prophylactic lesion revisions in both
roups, which explains the marked improvement in the
atency rates for failing (with 5- and 10-year assisted pri-
ary patency rates of 89% and 82% in group I) and failed
evascularizations (with 5- and 10-year secondary patency
ates of 93% and 86% in group I).
Patient education is a fundamental aspect of our proto-
ol. Patients are told about the risk of graft thrombosis and
he need for regular postoperative assessments to monitor
he patency of their graft. They are instructed to contact
heir physician immediately if symptoms of recurrent isch-
mia develop, and the vascular registry routinely reminds
hem, by telephone or mail, to attend their graft surveil-
ance appointments. During follow-up visits, patients are
dvised about how to reduce their risk factors, especially as
oncerns smoking.
Despite a similar proportion of AIOD reconstructions
eing performed for limb salvage in our younger and older
atients, we found, like some investigators14 and in con-
rast with others,15 that younger patients had a significantly
igher rate of subsequent infrainguinal revascularizations
han their older counterparts and that these peripheral
rterial reconstructions were prompted more by their pre-
ature PAD progressing than by graft failure. In addition,
ll major amputations occurred after repeated distal revas-
ularizations failed in patients with a patent proximal re-
onstruction. This finding suggests that the limb’s fate is
ictated by the infrainguinal disease being associated with
omplex AIOD, despite the protective effect of a patent
ortoiliac revascularization.
The following further points emerged from our study:
● Surgical reconstruction involved an end-to-side prox-
imal anastomosis in approximately two-thirds of the
younger patients, requiring concomitant endarterec-
tomy of the proximal site statistically less often than in
older patients (6% vs 17%, P  .02).
● The need for concomitant common femoral artery
endarterectomy (9% vs 20%, P  .03) or profundo-
plasty (19% vs 32%, P  .03) was statistically lower in
the younger group.
Like some authors,34 although we were unable to
easure the diameter of the infrarenal aortic segment, we
ound no evidence that graft size (as a surrogate measure of
he aorta’s size) influenced long-term patency or the risk of
imb loss. Other authors have reported, however, that
atients with smaller aortas had worse long-term patency
ates,7,14 finding a small aortic diameter often associated
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hemodynamic impairments, and less able to allow for inti-
mal hyperplasia,7,9,14 which could account for a faster
progression of premature PAD than in larger vessels.
This study has several limitations. First, the analysis is
naturally limited by its retrospective nature, although our
data were collected prospectively. Second, for a series of
patients spanning such a lengthy period, the numbers are
rather small. However, the TASC II lesions were compara-
ble in our two groups and so were the patients’ presenting
symptoms and the status of their atherosclerotic disease
(judging indirectly from their ABI values), indicating that
the burden of AIODwas much the same in the two groups,
warranting a technical homogeneity between them and
supporting the reliability of our results. All patients also
attended the same center and were treated by the same
surgeon, ensuring a uniform surgical approach.
CONCLUSIONS
This study shows that aortoiliofemoral revasculariza-
tion is a safe procedure for complex AIOD in younger
patients with premature PAD presenting with disabling
claudication or limb-threatening ischemia, providing the
patients comply with a close postoperative monitoring pro-
tocol and undergo graft revision if necessary. In this setting,
despite the higher primary graft failure rate, aortoiliac re-
construction in young adults carries minimal life-threatening
risks and achieves secondary patency and limb salvage rates
comparable with those seen in older patients with typical
atherosclerotic disease.
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